FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to medical products of antiischemic and hypolipidemic activity and can be used as new agent for correction of lipidic metabolic disorder to prevent and treat dyslipidemia, ischemic heart disease (IHD), and as rehabilitation agent at postinfarction conditions. Agent of antiischemic and hypolipidemic activity represents ecdysteroids-containing substance extracted from aerial saw-wort Serratula coronata L. (Asteraceae), containing mixed 20-hydroxyecdysone in amount not less than 75% and 25S-inocosterone in amount not less than 10%.
EFFECT: evident hypolipidemic activity and considerable reduction in common lipid, cholesterol and triglyceride content.
7 ex, 19 tbl, 24 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL FORMULATION IN SOLID DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2445091C1 |
CORONARY ACTIVE ANTI-ISCHEMIA AND ANTI-ARRHYTHMIA AGENT | 2005 |
|
RU2290927C1 |
ANTI-ISHEMIC AND ANTIHYPOXIC AGENT | 2007 |
|
RU2356573C1 |
1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (MT) | 2008 |
|
RU2404974C2 |
PHARMACEUTICAL COMPOSITION FROM GALLERIA MELLONELLA LARVAE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2741801C2 |
METHOD FOR CORRECTION OF LIPID PEROXIDATION PROCESSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2016 |
|
RU2627458C1 |
GAMMA-HYDROXYPROPYLAMMONIUM-5-HYDROXYNICOTINATE ELICITING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND HYPOLIPIDEMIC ACTIVITY | 2003 |
|
RU2245329C1 |
AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
METHOD FOR DIAGNOSTICS OF CORONARY REPERFUSION IN PATIENTS WITH MYOCARDIAL INFARCTION | 2000 |
|
RU2190847C2 |
Authors
Dates
2008-11-10—Published
2007-02-06—Filed